Results 161 to 170 of about 1,768,893 (247)

An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017. [PDF]

Influenza Other Respir Viruses, 2023
Sinnathamby MA, Warburton F, Reynolds AJ, Cottrell S, O'Doherty M, Domegan L, O'Donnell J, Johnston J, Yonova I, Elgohari S, Boddington NL, Andrews N, Ellis J, de Lusignan S, McMenamin J, Pebody RG.   +15 more
europepmc   +1 more source

Molecular Characterization of Human Adenoviruses Before and After a Severe HAdV‐7 Military Outbreak in Finland in 2024

Influenza and Other Respiratory Viruses, Volume 20, Issue 10, October 2026.
ABSTRACT Background In 2024, a severe outbreak caused by human adenovirus type 7d (HAdV‐7) occurred in Finnish military garrisons. Molecular typing was implemented to support outbreak control. The aim of this study was to determine adenovirus types circulating in Finnish garrisons during 2013–2023 by retrospective surveillance and to review earlier ...
Niko Tervo, Marjaana Pitkäpaasi, Pilvi Hepo‐oja, Hanna Jarva, Anna Katz, Erika Lindh, Richard Lundell, Minna Paloniemi, Laura Savolainen, Carita Savolainen‐Kopra, Niina Ikonen, Simo Nikkari   +11 more
wiley   +1 more source

Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein. [PDF]

Vaccines (Basel), 2023
Prokopenko P, Matyushenko V, Rak A, Stepanova E, Chistyakova A, Goshina A, Kudryavtsev I, Rudenko L, Isakova-Sivak I.   +8 more
europepmc   +1 more source

Reconstruction of native cellular microanatomy in a novel bioengineered full thickness human nasal mucosal construct

Journal of Anatomy, Volume 249, Issue 4, Page 950-969, October 2026.
Bioengineered tissue constructs are vital technologies employed in in vitro testing of both fundamental biological principles and industrial screening practices. Current approaches to modelling the nasal mucosa in vitro are not representative and are associated with limitations that impact their reliability and predictive value.
Steven Bradbury, Bethany Dickson, Nicola Curtis, David Bunton, Kirsty Goncalves, Stefan Przyborski   +5 more
wiley   +1 more source

Genotype II Live‐Attenuated ASFV Vaccine Bearing 24 Genes Deletion in 3 Independent Regions Is Able to Provide Complete Protection Against Homologous Lethal Challenge

The FASEB Journal, Volume 40, Issue 17, 15 September 2026.
African swine fever (ASF) is a highly contagious and lethal viral disease of swine. Therefore, it is urgent to develop a safe and effective vaccine. We constructed a live‐attenuated ASF vaccine bearing 24 gene deletions in 3 independent regions, ASFV‐Δ24.
Fan Xu, Wen Dang, Yu Du, Tao Li, Huanan Liu, Zhengwang Shi, Hong Tian, Jijun He, Haixue Zheng   +8 more
wiley   +1 more source

Detrimental impact of allergic airway disease on live attenuated influenza vaccine. [PDF]

Health Sci Rep, 2021
Roy S, Williams CM, Furuya Y.
europepmc   +1 more source

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector. [PDF]

Vaccines (Basel), 2022
Isakova-Sivak I, Stepanova E, Matyushenko V, Niskanen S, Mezhenskaya D, Bazhenova E, Krutikova E, Kotomina T, Prokopenko P, Neterebskii B, Doronin A, Vinogradova E, Yakovlev K, Sivak K, Rudenko L.   +14 more
europepmc   +1 more source

Influenza A and B Viral Shedding in Adults Immunized with Live Attenuated Influenza Vaccine. [PDF]

Clin Infect Dis
Tower BM, Liu CM, Diemert DJ, Nelson SG, Ware CE, Salazar JE, Pham T, Leventis RM, Rose KE, Roberts ALS, Weber NO, Sung EH, Aziz M, Troyer RM, Park DE.   +14 more
europepmc   +1 more source

The Live Attenuated Influenza Vaccine in Australia: An Additional Tool for Influenza Prevention. [PDF]

Med J Aust
Patel C, Pillsbury A, Nguyen T, Wang X, Quinn HE, Chiu CK, Cheng AC, Flanagan KL, Wang Z.   +8 more
europepmc   +1 more source

Erratum: Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children. [PDF]

Cell Rep Med, 2022
Costa-Martins AG, Mane K, Lindsey BB, Ogava RLT, Castro IC, Jagne YJ, Sallah HJ, Armitage EP, Jarju S, Ahadzie B, Ellis-Watson R, Tregoning JS, Bingle CD, Bogaert D, Clarke E, Ordovas-Montanes J, Jeffries D, Kampmann B, Nakaya HI, de Silva TI.   +19 more
europepmc   +1 more source